Skip Navigation


eCAM Advance Access originally published online on March 15, 2007
eCAM 2008 5(2):187-190; doi:10.1093/ecam/nem019
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
5/2/187    most recent
nem019v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kantamreddi, V. S. S.
Right arrow Articles by Wright, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kantamreddi, V. S. S.
Right arrow Articles by Wright, C. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2007 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Investigation of Indian Diospyros Species for Antiplasmodial Properties

V. S. Satyanarayana Kantamreddi and Colin W. Wright

The School of Pharmacy, University of Bradford, West Yorkshire, BD7 1DP, UK


   Abstract
Top
 Abstract
Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 
Despite decades of intense research, malaria remains a deadly disease worldwide and new antimalarials are urgently needed due to increasing drug resistance of Plasmodium falciparum to existing drugs. This article reports the evaluation of four Indian Diospyros species viz., Diospyros melanoxylon, D. peregrina, D. sylvatica, D. tomentosa for antiplasmodial activities against chloroquine-sensitive (3D7) and chloroquine-resistant (K1) strains of P. falciparum. Six of eight methanolic extracts were found to have significant activity, (IC50 = 16.5–92.9 µg ml–1), against strain 3D7 and five of these showed similar activities against strain K1 (IC50 = 20.5–121.6 µg ml–1). Diospyros sylvatica was found to be the most active species (IC50 = 16.5–29.4 µg ml–1) and is worthy of further investigation.

Keywords: Diospyros melanoxylon – Diospyros peregrina – Diospyros sylvatica – Diospyros tomentosa – Ebenaceae – Malaria – Plasmodium falciparum


   Introduction
Top
 Abstract
 Introduction
Methods
 Results
 Discussion
 Conclusion
 References
 
Malaria is one of the most devastating diseases in the world responsible for more than 2.5 million deaths (1) and at least 300 million clinical cases per annum (2). Resistance of Plasmodium falciparum to chloroquine and some other antimalarial drugs continuous to increase. Efforts are now being directed towards the discovery and development of new chemically diverse antimalarial agents. Diospyros is one of the most important genera of the Ebenaceae and Diospyros species are well-known for their medicinal uses since ancient times in many traditional medicinal systems such as Ayurveda, Traditional Chinese Medicine and the African folklore (3–9). About 41 Diospyros species occur in India of more than 350 species identified (10,11). These are mostly trees and rarely shrubs. The literature revealed that these plants contain pentacyclic triterpenes and juglone-based 1,4-naphthoquinones and about 130 species have undergone some phytochemical and/or pharmacological investigations (8).

Two in-vivo studies by different groups revealed that the methanolic extracts of Diospyros mespiliformis (bark) and D. variegata (stem) possessed potent antipyretic properties supporting their folkloric use in relieving fevers (12,13) suggesting that species of Diospyros may be worth screening for antimalarial properties. Diospyros melanoxylon, D. peregrina, D. sylvatica, D. tomentosa have been used extensively in Indian traditional medicine to treat for a variety of diseases including diarrhea, cholera, dysentery, intermittent fevers, bleeding gums, bronchitis, carbuncles, cough, cramps, pneumonia, syphilis, tumors, etc. (8,14) and are widely available in the forests of Orissa (North East India). Therefore, these species have been collected and used for antiplasmodial screening.


   Methods
Top
 Abstract
 Introduction
 Methods
Results
 Discussion
 Conclusion
 References
 
Plant Collection

Plant materials were collected from the local forest, Bhubaneswar (20°15' N, 85°50' E), Orissa, India during June–August 2004. The identity of these plants was confirmed by taxonomist, Mr Murty K.S. (Ayurvedic Research Institute, Bhubaneswar, India) and the voucher specimens (040511–040518) are kept available in The School of Pharmacy, University of Bradford, UK.

Extraction

Method 1. Dried pulverized plant material (10 g) was extracted with methanol at room temperature; the methanol was decanted after 24 h and the extraction repeated three times. The pooled extracts were filtered and then concentrated under vacuum using a rotary evaporator at 40°C.

Method 2. Powdered stem bark (10 g) of D. peregrina, D. sylvatica and D. tomentosa were extracted (separately) in a Soxhlet apparatus successively with n-hexane, ethyl acetate and methanol and the extracts concentrated under vacuum.

Sample Preparation

Crude extracts and control drugs stock solutions (1 mg ml–1) were prepared by weighing 1 mg accurately and dissolving in 50 µl of dimethyl sulphoxide (DMSO) or ethanol and made up to 1 ml with double distilled water. Later these solutions were diluted in complete medium.

Chemicals and Reagents

All the materials for the antiplasmodial assays were purchased from Sigma Chemical Co, Poole, UK, except for artemether which was a gift from Aventis Pharma.

Cultivation of P. falciparum

Chloroquine sensitive (3D7) and resistant (K1) strains were kindly supplied by Professor D. C. Warhurst (London School of Hygiene and Tropical Medicine). The strains were maintained in human A + erythrocytes suspended in RPMI 1640 medium supplemented with A + serum and D-glucose according methods of Trager and Jensen, 1976 (15) and Fairlamb et al. 1985 (16).

Antiplasmodial Assay

Cultures containing predominantly early ring stages of P. falciparum were used for testing. After adding sample solutions to 96-well microtiter plates in duplicate, 2-fold serial dilutions were made with RPMI 1640 medium and infected erythrocytes were added to give a final volume of 100 µl with 2.5% hematocrit and 1% parasitemia. Chloroquine diphosphate and artemether were used as positive controls, and uninfected and infected erythrocytes without sample solutions were incubated in each test. Plates were placed into a modular incubator gassed with 93% nitrogen, 3% oxygen and 4% carbon dioxide and incubated at 37°C for 48 h. Parasite growth was assessed by measuring parasite lactate dehydrogenase activity (pLDH) as described by Makler et al. 1993 (17). The reagent used contained the following in each micro-litre acetylpyridine adenine dinucleotide (APAD), 0.74 mg; lithium lactate, 19.2 mg; diaphorase, 0.1 mg; Triton X-100, 2 µl; nitroblue tetrazolium, 1 mg; and phenazine ethosulfate, 0.5 mg. Fifty microliters of this reagent was added to each well and mixed, and plates were read at 550 nm using a Dynatech Laboratories MRX microplate reader, and per cent inhibition of growth was calculated by comparison with control values. Optical densities were read at 550 nm using a Dynatech Laboratories MRX microplate reader and percentage inhibition of growth was calculated by comparison with control values. IC50 values were determined using linear regression analysis (Microsoft Excel). A minimum of three separate determinations was carried out for each sample.


   Results
Top
 Abstract
 Introduction
 Methods
 Results
Discussion
 Conclusion
 References
 
The antiplasmodial activities of the extracts and control drugs are shown in Tables 1 and 2. Data are expressed as the mean ± standard deviation of the IC50 of three independent experiments on different days for each strain. The IC50 values ranged from 16.5 to >500 µg ml–1. The effect of the methanolic extract of root, D. sylvatica on growth of P. falciparum strain K1 is shown in Fig. 1. No significant difference was found in IC50 values against strains 3D7 and K1 in the case of artemether (0.008 and 0.014 µg ml–1, respectively), but ~20-fold difference was found in CQ between the strains 3D7 and K1 (0.02 and 0.38 µg ml–1, respectively) showing that, as expected strain K1 is resistant to CQ, but not to artemether. The effect of CQ on growth of P. falciparum strain K1 is shown in Fig. 2.


View this table:
[in this window]
[in a new window]

  		Table 1. In vitro activities of MeOH extracts and antimalarial drugs against P. falciparum

 

View this table:
[in this window]
[in a new window]

  		Table 2. In vitro activities of successive extracts against P. falciparum

 

Figure 1
View larger version (10K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 1. Effect of extract of D. sylvatica on growth of P. falciparum strain K1.

 

Figure 2
View larger version (11K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 2. Effect of chloroquine diphosphate on growth of P. falciparum strain K1.

 

   Discussion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
Conclusion
 References
 
Six of the eight methanolic extracts from the four Diospyros species were found to have significant activities against strain 3D7 (IC50 ≤ 93 µg ml–1; see Table 1) and five extracts were active in case of strain K1 (IC50 ≤ 122 µg ml–1; see Table 1) suggesting that the latter do not exhibit cross-resistance with chloroquine. Interestingly, the extracts of D. sylvatica possessed very good activity (IC50 = 16.5–29.4 µg ml–1; see Table 1) against both strains 3D7 and K1 and were the most active of these Diospyros extracts. Diospyros melanoxylon, stem heartwood and root possessed significant activities against strain 3D7 (IC50 = 55.6 and 78.4 µg ml–1, respectively), but the heartwood extract was 2-fold less active against strain K1 compared with strain 3D7 (IC50 = 201.7 and 121.6 µg ml–1, respectively). Diospyros peregrina stem bark possessed activity against both strains 3D7 & K1 (IC50 = 92.9 and 120.2 µg ml–1, respectively). Methanolic extracts of the stem barks of D. melanoxylon and D. tomentosa were inactive (IC50 > 500 µg ml–1). Stem barks of D. peregrina, D. sylvatica and D. tomentosa were fractionated successively with n-hexane, ethyl acetate and methanol and screened against both parasite strains (Table 2). Only the methanolic fraction from D. peregrina was active while in the case of D. sylvatica the ethyl acetate fraction was the most active, but some activity remained in the methanol fraction. No activity was seen in the fractions from D. tomentosa, consistent with the lack of activity found in the cold methanolic extract.

A literature study of Diospyros species revealed that only the leaves of D. melanoxylon have previously been tested against P. falciparum (3D7) and the ethanolic extract was found to be active (IC50 = 97 µg ml–1) (18). Diospyros peregrina, D. sylvatica, D. tomentosa and the root, heartwood and stem bark of D. melanoxylon have been screened for the first time in this study.

A large number of compounds have been reported from D. melanoxylon and D. peregrina including lupeol, betulin, betulinic acid, ursolic acid, oleanolic acid, β-sitosterol, etc. (8). A few studies have been carried out with D. sylvatica. Lupeol, betulin and betulinic acid have been isolated from the bark (19) and 2-methylanthraquinone, plumbagin, diosindigo, diospyrin, iso-diospyrin and microphyllone reported from roots by Ganapaty et al. 2004 (20). The antiplasmodial activities of some of these compounds have been reported (21–27); plumbagin (25) and diospyrin (26) have been shown to have potent activities against P. falciparum in vitro (IC50 = 0.27 and 0.21 µg ml–1, respectively) while betulinic acid and lupeol, ursolic acid and oleanolic acid were only weakly active. The presence of these compounds, especially plumbagin and diospyrin may explain the antiplasmodial activities of the extracts tested in this study but further studies will be needed in order to confirm this.


   Conclusion
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
References
 
Extracts of three of the four species of Indian Diospyros tested in this study showed antiplasmodial activities, with the best activity shown by D. sylvatica. This species especially is worthy of further investigation to determine which of its constituents are responsible for the activity.


  Footnotes
 
For reprints and all correspondence: V. S. Satyanarayana Kantamreddi, University of Bradford, Bradford West Yorkshire BD7 1DP, UK. Tel: +44 0 1274 234745; Fax: +44 0 1274 234660; E-mail: v.s.s.kantamreddi{at}bradford.ac.uk; vssn_k{at}yahoo.com


   Acknowledgments
 
V.S.S.K. expresses his gratitude to the Association of Commonwealth Universities, UK for financial support and to Dr U. V. Mallavadhani and Mr K. R. Kaushal from the Regional Research Laboratory, Bhubaneswar for their scientific support.


   References
Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Conclusion
 References
 

  1. Sachs J, Malaney P. The economic and social burden of malaria. Nature ( 2002;) 415:: 680–5.[CrossRef][Medline]
  2. WHO. World Health Organization Fact Sheet No. 94. In: WHO information ( 2003;) <http://www.int/inf~fs/en/fact094.html>.
  3. Laloo RC, Kharlukhi L, Jeeva S, Mishra BP. Status of medicinal plants in the disturbed and the undisturbed sacred forests of Meghalaya, northeast India: population structure and regeneration efficacy of some important species. Current Science ( 2006;) 90:: 225–232.[Web of Science]
  4. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants ( 1956;) New Delhi, India: CSIR. 98–9.
  5. Kirtikar KR, Basu BD. Indian Medicinal Plants —Blatter E, Cains JF, Mhaskar KS, eds. ( 1933;) Allahabad, India: Lalit Mohan Basu. 1498.
  6. Lewis WH, Elvin-Lewis MPF. Medical Botany: Plants Affecting Man's Health ( 1977;) New York: Wiley Interscience.
  7. Phongboonrod S. Medicinal Plants of Thailand ( 1979;) Bangkok: Kasem Banakit.
  8. Mallavadhani UV, Panda AK, Rao YR. Pharmacology and chemotaxonomy of Diospyros. Phytochemistry ( 1998;) 49:: 901–51.[CrossRef][Web of Science][Medline]
  9. Bhushan P, Dnyaneshwar W, Pushpangadan P, Narendra B. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternative Med ( 2005;) 2:: 465–73.[CrossRef]
  10. George Watt MB. A Dictionary of the Economic Products of India ( 1952;) New Delhi, India: Cosmo Publication. 136.
  11. Sastry BN. The Wealth of India: Raw Materials ( 1952;) New Delhi, India: CSIR. 76.
  12. Adzu B, Amos S, Dzarma S, Muazzam I, Gamaniel KS. Pharmacological evidence favouring the folkloric use of Diospyros mespiliformis Hochst in the relief of pain and fever. J Ethnopharmacol ( 2002;) 82:: 191–5.[CrossRef][Web of Science][Medline]
  13. Trongsakul S, Panthong A, Kanjanapothi D, Taesotikul T. The analgesic, antipyretic and anti-inflammatory activity of Diospyros variegata Kruz. J Ethnopharmacol ( 2003;) 85:: 221–5.[CrossRef][Web of Science][Medline]
  14. Jain S, DeFilipps R. Medicinal Plants of India ( 1991;) Algonac, Michigan: Reference Publications, Inc. 286.
  15. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science ( 1976;) 193:: 673–5.[Abstract/Free Full Text]
  16. Fairlamb AH, Warhurst DC, Peters W. An improved technique for the cultivation of Plasmodium falciparum in vitro without daily medium change. Ann Trop Med Parasitol ( 1985;) 79:: 379–84.[Web of Science][Medline]
  17. Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg ( 1993;) 48:: 739–41.[Abstract/Free Full Text]
  18. Simonsen HT, Nordskjold JB, Smitt UW, Nyman U, Palpu P, Joshi P, et al. In vitro screening of Indian medicinal plants for antiplasmodial activity. J Ethnopharmacol ( 2001;) 74:: 195.[CrossRef][Web of Science][Medline]
  19. Row L, Sankara R, Ramaiah T. Chemical examination of Diospyros species. IV. Triterpenes of the leaves of D. sylvatica and D. melanoxylon. Current Science ( 1966;) 35:: 485.
  20. Ganapaty S, Thomas PS, Fotso S, Laatsch H. Antitermitic quinones from Diospyros sylvatica. Phytochemistry ( 2004;) 65:: 1265–71.[CrossRef][Web of Science][Medline]
  21. Steele JC, Warhurst DC, Kirby GC, Simmonds MS. In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother Res ( 1999;) 13:: 115–9.[CrossRef][Web of Science][Medline]
  22. Bringmann G, Saeb W, Assi LA, Francois G, Sankara Narayanan AS, Peters K, et al. Betulinic acid: isolation from Triphyophyllum peltatum and Ancistrocladus heyneanus, antimalarial activity, and crystal structure of the benzyl ester. Planta Med ( 1997;) 63:: 255–7.[CrossRef][Web of Science][Medline]
  23. Alves TM, Nagem TJ, de Carvalho LH, Krettli AU, Zani CL. Antiplasmodial triterpene from Vernonia brasiliana. Planta Med ( 1997;) 63:: 554–5.[Web of Science][Medline]
  24. Amusan OOG. Antimalarial active principles of Spathodea campanulata stem bark. Phytother Res ( 1996;) 10:: 692–3.[CrossRef][Web of Science]
  25. Likhitwitayawuid K, Kaewamatawong R, Ruangrungsi N, Krungkrai J. Antimalarial naphthoquinones from Nepenthes thorelii. Planta Med ( 1998;) 64:: 237–41.[CrossRef][Web of Science][Medline]
  26. Hazra B, Ghosh R, Banerjee A, Kirby GC, Warhurst DC, Phillipson JD. In-Vitro antiplasmodial effects of Diospyrin, a plant-derived Naphthoquinoid, and a novel series of derivatives. Phytother Res ( 1995;) 9:: 72–4.[CrossRef][Web of Science]
  27. Selma R, Shirley da S, Maria RF M. Plumbagine: a pharmacological approach. Floresta e Ambiente ( 2003;) 10:: 98–105.
Received August 16, 2006; accepted January 16, 2007


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
5/2/187    most recent
nem019v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kantamreddi, V. S. S.
Right arrow Articles by Wright, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kantamreddi, V. S. S.
Right arrow Articles by Wright, C. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?